SRC and cancer: Besides p53, several reports has indicated that JNK, ERK, p38, NFκB, WNT/β‐catenin, AKt/sp1/NOx4, and Src/FAK pathways also modulate BTG2 expressions in different cancer cells 28, 29, 30, 31, 32.